A Test on a New Experimental Mouth Rinse for Relieving Tooth Sensitivity
NCT ID: NCT01727258
Last Updated: 2015-06-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
153 participants
INTERVENTIONAL
2012-12-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
During the first 2 weeks, participants will brush their teeth two times a day with the fluoride toothpaste provided.
Then, if they qualify to continue in the study, participants will be assigned to a treatment group. All the groups will get toothpaste currently sold on the market, and one group will get a mouthwash with an experimental ingredient to use as well. Subjects will have an equal chance of being assigned to any one of the three groups.
For the next 4 weeks, subjects will use their assigned products according to the directions provided. At Visit 1 subjects will be supervised while they brush their teeth to ensure they understand the directions. They will also have supervised use of the product at Visit 2.
We will see if the mouthwash helps to reduce tooth sensitivity during the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Relief of Tooth Sensitivity of an Experimental Mouthrinse Device
NCT01345292
Test on a New Experimental Mouth Rinse for Relieving Tooth Sensitivity
NCT02113579
Tooth Sensitivity Relief by Two Mouthrinses
NCT01133379
Clinical Study Investigating the Efficacy of a Mouthwash in Providing Long Term Relief From Dentinal Hypersensitivity
NCT02226562
A Clinical Study to Assess the Effects of Various Dentifrice Technologies on Dentinal Hypersensitivity
NCT03965039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Run-in will consist of a 2-week period during which subjects will use a sodium fluoride dentifrice. At the start of the first phase, subjects will attend a Screening Visit. They will participate in the informed consent process, complete a medical/dental history, and be evaluated for tactile sensitivity to Yeaple probe and response to a cold air stimulus.
Subjects who qualify through screening will begin a run-in period that will last approximately two weeks. The run-in period will be followed by a Baseline visit. Subjects who continue to qualify through Baseline will be randomized to one of three treatment groups.
During the four-week treatment period, all subjects will brush their teeth twice daily for at least one minute in their usual manner, with their assigned toothpaste. After brushing, subjects assigned to the mouth rinse group will rinse with water, and then rinse with 10 mL of the experimental mouth rinse for 60 seconds.
The study duration is approximately six weeks with each subject visiting the clinical site six times.
Adverse events will be observed and collected by querying each subject at each visit for new or continuing symptoms.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mouth Rinse
Twice daily for 28 days, brush in usual manner for at least one minute using at least a one-inch strip of Fluoride Toothpaste provided. Rinse with water after brushing teeth. Then rinse for 60 seconds with 10 mL of the experimental Mouth Rinse 12027-033 (KOX).
Mouth Rinse
Mouth rinse 12027-033 used twice daily for 28 days after brushing.
Fluoride Toothpaste
Fluoride Toothpaste used daily for 28 days.
Fluoride Toothpaste
Twice daily for 28 days, brush in usual manner for at least one minute using at least a one-inch strip of the Fluoride Toothpaste (NEG) provided.
Fluoride Toothpaste
Fluoride Toothpaste used daily for 28 days.
Potassium Nitrate Toothpaste
Twice daily for 28 days, brush in usual manner for at least one minute using at least a one-inch strip of the Potassium Nitrate Toothpaste (POS) provided.
Potassium Nitrate Toothpaste
Potassium Nitrate Toothpaste used daily for 28 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mouth Rinse
Mouth rinse 12027-033 used twice daily for 28 days after brushing.
Fluoride Toothpaste
Fluoride Toothpaste used daily for 28 days.
Potassium Nitrate Toothpaste
Potassium Nitrate Toothpaste used daily for 28 days.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Evidence of a personally signed and dated informed consent document indicating the subject (or legally acceptable representative) has been informed of all pertinent aspects of the trial
* Willingness to use the assigned products according to instructions, availability for appointments, and likelihood of completing the clinical trial
* Dental condition appropriate for inclusion in the trial according to protocol-specified parameters and the professional opinion of the investigator
* Adequate oral hygiene (i.e. brush teeth daily and exhibit no signs of oral neglect
Exclusion Criteria
* Use of home-care bleaching, whitening products or professional bleaching treatment within a protocol-specified time period
* Use of desensitizing agents within a protocol-specified time period
* Participation in a dental clinical trial involving oral care products within a protocol-specified time period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Consumer and Personal Products Worldwide
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Lynch, DMD, PhD
Role: STUDY_DIRECTOR
Johnson & Johnson Consumer and Personal Products Worldwide
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BioSci Research America, Inc.
Las Vegas, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KOXDHY0008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.